ArticleCureus2026
When Hard Doesn't Mean Malignant: A Benign Axillary Finding in Lobular Carcinoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 50-year-old premenopausal woman presented with an abnormal screening mammogram, which led to the diagnosis of grade 2 invasive lobular carcinoma of the left breast with axillary lymph node metastases. Immunohistochemistry confirmed lobular origin with estrogen receptor (ER)/progesterone receptor (PR) positivity and Human Epidermal Growth Factor Receptor 2 (HER2) negativity. Neoadjuvant chemotherapy with cyclophosphamide and docetaxel was followed by a sentinel lymph node biopsy, which revealed three metastatic nodes. A modified radical mastectomy with axillary dissection was subsequently performed. Postoperative pathology showed residual invasive lobular carcinoma measuring 1.7 cm, with negative surgical margins and angiolymphatic invasion. Notably, a hard axillary mass excised during dissection revealed a rare benign chondroid and osseous metaplastic reaction. This histologic finding, although non-malignant, may be confused with nodal disease intraoperatively or on imaging, underscoring the importance of thorough pathologic analysis. The patient completed post-mastectomy radiation therapy to the chest wall and regional lymphatics and was started on ovarian suppression and endocrine therapy with a Cyclin-dependent Kinase (CDK)4/6 inhibitor. Genetic testing was negative, and there was no family history of breast or ovarian cancer. This case draws attention to an uncommon histopathological response that may follow trauma or biopsy in breast cancer patients and reinforces the need for clinical awareness when interpreting persistent axillary findings post-treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.